Skip to main content
Top
Published in: Supportive Care in Cancer 5/2019

01-05-2019 | Letter to the Editor

Commentary on: Quality of life in oropharyngeal cancer: a structured review of the literature

Authors: Miriam Allein Zago Marcolino, Rafaela Soares Rech

Published in: Supportive Care in Cancer | Issue 5/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Roets E, Tukanova K, Govarts A, Specenier P (2018) Quality of life in oropharyngeal cancer: a structured review of the literature. Support Care Cancer:1–8 Roets E, Tukanova K, Govarts A, Specenier P (2018) Quality of life in oropharyngeal cancer: a structured review of the literature. Support Care Cancer:1–8
3.
go back to reference Binenbaum Y, Amit M, Billan S, Cohen JT, Gil Z (2014) Minimal clinically important differences in quality of life scores of oral cavity and oropharynx cancer patients. Ann Surg Oncol 21(8):2773–2781CrossRefPubMed Binenbaum Y, Amit M, Billan S, Cohen JT, Gil Z (2014) Minimal clinically important differences in quality of life scores of oral cavity and oropharynx cancer patients. Ann Surg Oncol 21(8):2773–2781CrossRefPubMed
4.
go back to reference Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available in: www.cochrane-handbook.org. Accessed on 04 Oct 2018 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available in: www.​cochrane-handbook.​org. Accessed on 04 Oct 2018
Metadata
Title
Commentary on: Quality of life in oropharyngeal cancer: a structured review of the literature
Authors
Miriam Allein Zago Marcolino
Rafaela Soares Rech
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4549-7

Other articles of this Issue 5/2019

Supportive Care in Cancer 5/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine